M

Mustang Bio
D

MBIO

0.16780
USD
-0.01
(-4.06%)
Market Open
Volume
5,510
EPS
-1
Div Yield
-
P/E
-0
Market Cap
8,325,271
OverviewSignalsIdeasNews
Related Instruments
    A
    ADUS
    -1.395
    (-1.06%)
    130.095 USD
    C
    CODX
    -0.01000
    (-1.37%)
    0.72000 USD
    I
    INO
    -0.02000
    (-1.09%)
    1.81000 USD
    O
    OPK
    -0.02500
    (-1.62%)
    1.51500 USD
    V
    VBIV
    0.000000
    (0.00%)
    0.000000 USD
    V
    VXRT
    -0.00450
    (-0.73%)
    0.60810 USD
    More
News

Title: Mustang Bio

Sector: Healthcare
Industry: Biotechnology
Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipelineis currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.